Toxta 100/200UI – Next-Generation Korean Botulinum Toxin Type A

Toxta is a premium botulinum toxin type A developed in South Korea, designed to provide precise, long-lasting results in both aesthetic and therapeutic applications. With its high purity and optimal molecular weight (900 kDa), Toxta ensures predictable diffusion, smooth injection, and consistent outcomes with minimal risk of adverse reactions.

Clinics and medical professionals choose Toxta 100UI and 200UI for:

• Wrinkle reduction in forehead, glabella, and crow’s feet areas

• Facial contouring and muscle relaxation treatments

• Hyperhidrosis management (excessive sweating)

• Safe and natural aesthetic results

Key advantages of Toxta:

• Stable formulation with rapid onset and durable effect

• Low immunogenicity and excellent patient tolerance

• High-purity manufacturing under strict GMP standards

• Available in 100UI and 200UI doses for flexible clinical use

For distributors and clinics, Toxta offers a trusted Korean alternative to global toxin brands, combining advanced biotechnology, consistent clinical results, and excellent profitability for the professional aesthetic market.